BCM
OM icon

Bayesian Capital Management’s Outset Medical OM Stock Holding History

Bayesian Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,007
Closed -$390K – 1010
2022
Q4 		$390K Buy
1,007
+31
+3% +$8.74K 0.06% 416
2022
Q3 		$233K Buy
+976
New +$261K 0.05% 488

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Bayesian Capital Management's OM Position: Q1 2023 in Review

Bayesian Capital Management sold out of Outset Medical (OM) in Q1 2023, closing a stake of 1,007 shares — an estimated $390K sold.

Bayesian Capital Management first reported a position in OM in Q3 2022 and held it in 2 quarters. The position peaked at $390K in Q4 2022. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

  • Bayesian Capital Management reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 1,007 Outset Medical shares in Q1 2023, an estimated $390K.
  • Bayesian Capital Management first reported a position in Outset Medical in Q3 2022 and held it in 2 quarters.
  • Bayesian Capital Management's Outset Medical position peaked at $390K in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.